Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: An updated retrospective study on local failure and survival rates

References

• Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60: 615–22.
   PubMed Web of Science ®Google Scholar
• Kopek N, Paludan M, Petersen J, Hansen AT, Grau C, Høyer M. Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer. Radiother Oncol 2009;93:402–7.
   PubMed Web of Science ®Google Scholar
• Janssen-Heijnen ML, Smulders S, Lemmens VE, Smeenk FW, van Geffen HJ, Coebergh JW. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 2004;59:602–7.
   PubMed Web of Science ®Google Scholar
• Sirzen F, Kjellen E, Sorenson S, Cavallin-Stahl E. A systematic overview of radiation therapy effects in non- small cell lung cancer. Acta Oncol 2003;42:493–515.
   PubMed Web of Science ®Google Scholar
• Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiot Oncol Biol Phys 2012;83:348–53.
   PubMed Web of Science ®Google Scholar
• Ricardi U, Filippi AR, Guarneri A, Giglioli FR, Ciammella P, Franco P, et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial. Lung Cancer 2010;68:72–7.
   PubMed Web of Science ®Google Scholar
• Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303: 1070–6.
   PubMed Web of Science ®Google Scholar
• Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;75:677–82.
   PubMed Web of Science ®Google Scholar
• Baumann P, Nyman J, Høyer M, Wennberg B, Gagliardi G, Lax I, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009;27:3290–6.
   PubMed Web of Science ®Google Scholar
• Fowler JF, Tomé WA, Fenwick JD, Mehta MP. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 2004;60:1241–56.
   PubMed Web of Science ®Google Scholar
• Jeppesen S, Schytte T, Jensen HR, Brink C, Hansen O. Stereotactic body radiation therapy versus high-dose conventional radiation therapy in early-stage NSCLC: A retrospective study on local failure and survival rates. J Clin Oncol 2011;29:(Suppl; abstr 7049).
   Google Scholar
• Kong FM, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005;63:324–33.
   PubMed Web of Science ®Google Scholar
• Metha M, Manon R. Are more aggressive therapies able to improve treatment of locally advanced non-small cell lung cancer: Combined MODALITY Treatment?. Semin Oncol 2005;32:25–34.
   PubMedGoogle Scholar
• Grills IS, Hope AJ, Guckenberger M, Kestin LL, Werner-Wasik M, Yan D, et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone- beam computed tomography image-guided radiotherapy. J Thorac Oncol 2012;7:1382–93.
   PubMed Web of Science ®Google Scholar
• Kaskowitz L, Graham MV, Emami B, Halverson KJ, Rush C. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993;27:517–23.
   PubMed Web of Science ®Google Scholar
• van Baardwijk A, Tomé WA, van Elmpt W, Bentzen SM, Reymen B, Wanders R, et al. Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill?. A systematic review. Radiother Oncol 2012;105:145–9.
   PubMed Web of Science ®Google Scholar
• Stauder MC, Macdonald OK, Olivier KR, Call JA, Lafata K, Mayo CS, et al. Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiother Oncol 2011;99:166–71.
   PubMed Web of Science ®Google Scholar
• Baumann P, Nyman J, Hoyer M, Gagliardi G, Lax I, Wennberg B, et al. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother Oncol 2008;88:359–67.
   PubMed Web of Science ®Google Scholar
• Soliman M, Yaromina A, Appold S, Zips D, Reiffenstuhl C, Schreiber A, et al. GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: Subgroup analysis of the prospective randomized CHARTWEL trial. Radiother Oncol 2013; 106:299–344.
   PubMed Web of Science ®Google Scholar
• Ball D. Hypofractionated radiotherapy (stereotactic) versus conventional radiotherapy for inoperable early stage I non-small cell lung cancer (NSCLC) [Internet]. The National Library of Medicine Database (US). [Updated 2009 Nov 12]. Available from http://www.clinicaltrials.gov/ct2/show/study/NCT01014130?term = CHISEL& rank = 1
   Google Scholar
• Turzer M, Brustugun OT, Waldeland E, Helland Å. Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidity. Case Rep Oncol 2011;4:25–34.
   PubMedGoogle Scholar